US Broker Ratings

CytomX Therapeutics, Inc. (CTMX): Investor Outlook with a 45.91% Potential Upside

CytomX Therapeutics, Inc. (CTMX) has recently captured the attention of investors in the biotechnology sector due to its innovative approach in developing oncology-focused therapeutics. Based in South San Francisco, California,..

Fair Isaac Corporation (FICO) Stock Analysis: Unpacking a 23.78% Potential Upside for Investors

Fair Isaac Corporation (NYSE: FICO), a stalwart in the technology sector, is making waves with a compelling 23.78% potential upside, capturing the attention of investors. Specializing in advanced analytics and..

Aurora Cannabis Inc. (ACB) Stock Analysis: Exploring a 38.77% Potential Upside Amidst Industry Challenges

Aurora Cannabis Inc. (NYSE: ACB) is a prominent player in the healthcare sector, specifically within the drug manufacturing industry, where it focuses on both specialty and generic products. Established in..

Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Exploring a 114.65% Potential Upside in Cancer Treatment Innovations

Alpha Tau Medical Ltd. (NASDAQ: DRTS), an innovative player in the biotechnology sector, is making significant strides in the field of oncology therapeutics. Headquartered in Jerusalem, Israel, the company is..

Exxon Mobil (XOM) Stock Analysis: Exploring a Potential 11.93% Upside Amid Market Volatility

Exxon Mobil Corporation (NYSE: XOM), a stalwart in the energy sector, continues to capture investor attention with its extensive global operations and a potential upside of 11.93% based on analyst..

Anbio Biotechnology (NNNN): Evaluating the Performance and Growth Prospects of a Dynamic German Healthcare Firm

Anbio Biotechnology, trading under the symbol NNNN, is a dynamic player in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. Based in Frankfurt am Main, Germany, the..

TotalEnergies SE (TTE) Stock Analysis: A Promising 13.94% Upside in the Energy Sector

TotalEnergies SE (TTE), a global energy powerhouse headquartered in Courbevoie, France, continues to capture investor attention with its diverse portfolio and strategic positioning in the integrated oil and gas industry...

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating the Challenges and Opportunities in the Veterinary Vaccine Market

Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT) stands as a notable player in the healthcare sector, specializing in the development and production of veterinary vaccines. Despite its niche focus, the company..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: A Biotech Powerhouse with 376% Return on Equity

Rigel Pharmaceuticals, Inc. (RIGL) stands out in the biotechnology sector, showcasing remarkable metrics that could capture the attention of investors seeking growth in the healthcare domain. With a market cap..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Exploring a 65% Potential Upside in Biotech Innovation

Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a clinical-stage biopharmaceutical company with a market cap of $425.91 million, presents an intriguing opportunity for investors seeking exposure to the biotechnology sector. Headquartered in..

Alpha Teknova, Inc. (TKNO) Stock Analysis: A Healthcare Innovator with Over 100% Potential Upside

Alpha Teknova, Inc. (NASDAQ: TKNO) is making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in Hollister, California, this innovative company focuses on..

Evolent Health, Inc (EVH) Stock Analysis: A Potential 130% Upside Amidst Industry Challenges

Evolent Health, Inc (NYSE: EVH), a notable player in the healthcare sector, has garnered attention for its innovative approach to managing specialty care services, particularly in oncology, cardiology, and musculoskeletal..

Harrow, Inc. (HROW) Stock Analysis: Eyeing an 89.59% Upside in the Ophthalmic Pharmaceutical Arena

Harrow, Inc. (HROW) is capturing investor attention with its promising potential upside of nearly 90%, as indicated by recent analyst ratings. Operating in the healthcare sector, specifically within the specialized..

Aveanna Healthcare (AVAH) Stock Analysis: Navigating Growth in Home Healthcare with a 2.14% Upside

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) is carving a niche in the healthcare sector by focusing on delivering patient-centered care directly to homes, thereby minimizing the need for costly healthcare..

89bio, Inc. (ETNB) Investor Outlook: Potential 104% Upside as Biotech Innovator Gains Ground

Investors with a keen eye on the biotechnology sector may want to consider 89bio, Inc. (NASDAQ: ETNB), a promising clinical-stage biopharmaceutical company currently making waves with its innovative approach towards..

BioLife Solutions, Inc. (BLFS) Stock Analysis: 13% Potential Upside Amidst Strong Buy Ratings

BioLife Solutions, Inc. (NASDAQ: BLFS), a pivotal player in the healthcare sector’s medical instruments and supplies industry, is catching the eyes of investors with its promising growth trajectory and favorable..

Pediatrix Medical Group, Inc. (MD) Stock Report: Navigating Market Challenges with Strong Free Cash Flow

Investors keen on the healthcare sector may want to keep an eye on Pediatrix Medical Group, Inc. (MD), a prominent player in the medical care facilities industry. With a market..

Evotec SE (EVO) Stock Analysis: Unveiling a 34% Potential Upside in the Biotech Frontier

Evotec SE (NASDAQ: EVO), a prominent player in the healthcare sector, specifically within the niche of drug manufacturing, stands out as an intriguing opportunity for investors with a penchant for..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Innovator Eyes 138% Potential Upside

Wave Life Sciences Ltd. (WVE), a Singapore-based biotechnology firm, is capturing investor interest with its innovative approach to RNA medicine. The company, which operates in the healthcare sector, is making..

Ocular Therapeutix, Inc. (OCUL) Investor Outlook: Analyzing a Potential 92% Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a noteworthy player in the biotechnology sector, particularly within the healthcare industry, where it has carved out a niche in the development and commercialization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds